Natera, Inc. Share Price & Technical Analysis
NTRA · $203.2 (-0.25%)
Healthcare / Diagnostics & Research
$203.2
-0.25%
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehen…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-1% return in May, 4% avg return in past 3 year May month.
-7% return in 2026, 75% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 1% | -9% | 0% | 3% | -1% | – | – | – | – | – | – | – | -7% |
| 25 | 11% | -10% | -8% | 6% | 4% | 7% | -20% | 27% | -3% | 24% | 20% | -4% | 55% |
| 24 | 7% | 30% | 6% | 2% | 15% | 0% | -6% | 15% | 7% | -5% | 39% | -4% | 106% |
| 23 | 5% | 12% | 14% | -7% | -7% | 4% | -7% | 30% | -26% | -9% | 44% | 12% | 64% |
| 22 | -22% | -7% | -38% | -14% | 5% | -3% | 32% | 6% | -10% | 6% | -14% | -2% | -61% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Uptrend
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$28.72B
P/E ratio
—
52W high
$256.4
52W low
$131.8
Volume
10,36,809
Beta
1.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Natera, Inc. share price today?
- Natera, Inc. (NTRA) last traded around $203.2 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NTRA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NTRA. Download the app for real-time alerts.
- How can I analyze Natera, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.